The Manila Times

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging

FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting.The designation recognizes the program ...
Stocks Down Under

Telix Pharmaceuticals (ASX:TLX) FDA Fast Track Could Unlock Its Next Major Growth Market

Telix Pharmaceuticals (ASX:TLX) has secured FDA Fast Track for its BiPASS program, opening the pre-biopsy prostate cancer ...
1News

Who should get a PSA test for prostate cancer?

PSA is a prostate test, not a cancer test. Any breakdown in the cells of the prostate can make it leak. A raised result could ...
UCLA Health

ASTRO: Targeted radioactive therapy for prostate cancer, new SBRT approaches, personalized radiation and more

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...
Opinion
Renal & Urology NewsOpinion

Clinically Significant Prostate Cancer Detection: Is Prostate Imaging the New PSA?

Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.

A QUEBEC FIRST: MEDVUE CONCORDE ACQUIRES NEXT-GENERATION MRI SYSTEM POWERED BY ARTIFICIAL INTELLIGENCE

Medvue Concorde medical imaging clinic has become the first in Quebec to acquire the Siemens MAGNETOM Flow.Elite, a next-generation magnetic resonance imaging (MRI) system that integrates artificial ...